Hokland P - Search Results

1

Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.

Grövdal M, Karimi M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Holm MS, Tangen JM, Wallvik J, Oberg G, Hokland P, Jacobsen SE, Porwit A, Hellström-Lindberg E. Grövdal M, et al. Among authors: hokland p. Br J Haematol. 2010 Aug;150(3):293-302. doi: 10.1111/j.1365-2141.2010.08235.x. Epub 2010 May 20. Br J Haematol. 2010. PMID: 20497178 Free article. Clinical Trial.

2

Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes.

Kristensen JS, Hokland P. Kristensen JS, et al. Among authors: hokland p. Br J Haematol. 1990 Mar;74(3):270-6. doi: 10.1111/j.1365-2141.1990.tb02582.x. Br J Haematol. 1990. PMID: 2334636

3

Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies.

Bonde J, Meyer K, Broe MK, Hokland M, Turley H, Hokland P. Bonde J, et al. Among authors: hokland m, hokland p. Br J Haematol. 1996 Feb;92(2):269-79. Br J Haematol. 1996. PMID: 8602985

4

Relation of blast cell survival and proliferation to chemotherapy resistance in AML.

Nørgaard JM, Langkjer ST, Palshof T, Clausen N, Pedersen B, Hokland P. Nørgaard JM, et al. Among authors: hokland p. Br J Haematol. 1996 Jun;93(4):888-97. doi: 10.1046/j.1365-2141.1996.d01-1735.x. Br J Haematol. 1996. PMID: 8703822

5

MDR1 gene expression and drug resistance of AML cells.

Nørgaard JM, Bukh A, Langkjer ST, Clausen N, Palshof T, Hokland P. Nørgaard JM, et al. Among authors: hokland p. Br J Haematol. 1998 Mar;100(3):534-40. doi: 10.1046/j.1365-2141.1998.00593.x. Br J Haematol. 1998. PMID: 9504636 Free article.

6

Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia.

Aggerholm A, Guldberg P, Hokland M, Hokland P. Aggerholm A, et al. Among authors: hokland m, hokland p. Cancer Res. 1999 Jan 15;59(2):436-41. Cancer Res. 1999. PMID: 9927059

7

Natural effector cells in patients with acute myeloid leukemia treated with the immunomodulator Linomide after autologous bone marrow transplantation.

Hokland M, Jørgensen H, Holm MS, Simonsson B, Nilsson B, Bengtsson M, Hokland P. Hokland M, et al. Among authors: hokland p. Eur J Haematol. 1999 Oct;63(4):251-8. doi: 10.1111/j.1600-0609.1999.tb01886.x. Eur J Haematol. 1999. PMID: 10530414 Clinical Trial.

8

Dynamic cell cycle kinetics of normal CD34+ cells and CD38+/- subsets of haemopoietic progenitor cells in G-CSF-mobilized peripheral blood.

Holm M, Thomsen M, Høyer M, Hokland P. Holm M, et al. Among authors: hokland p. Br J Haematol. 1999 Jun;105(4):1002-13. doi: 10.1046/j.1365-2141.1999.01468.x. Br J Haematol. 1999. PMID: 10554814 Free article.

9

DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?

Aggerholm A, Hokland P. Aggerholm A, et al. Among authors: hokland p. Blood. 2000 May 1;95(9):2997-9. Blood. 2000. PMID: 10841615 Free article. No abstract available.

10

Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.

Aggerholm A, Grønbaek K, Guldberg P, Hokland P. Aggerholm A, et al. Among authors: hokland p. Eur J Haematol. 2000 Aug;65(2):109-13. doi: 10.1034/j.1600-0609.2000.90181.x. Eur J Haematol. 2000. PMID: 10966170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page